{"slideshow_credits": null, "snippet": "The study was testing the use of genetically engineered cells as a treatment for cancer, which had shown promising earlier results....", "abstract": "Food and Drug Admin halts Juno Therapeutics clinical trial following deaths of three patients from brain swelling; complications from side effects slow promising cancer therapy that involved genetically engineered cells; Juno shares fall 27 percent on news. ", "section_name": "Business Day", "print_page": "6", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK"}, "web_url": "http://www.nytimes.com/2016/07/08/business/juno-halts-cancer-trial-using-gene-altered-cells-after-3-deaths.html", "lead_paragraph": "The study was testing the use of genetically engineered cells as a treatment for cancer, which had shown promising earlier results.", "headline": {"main": "Juno Halts Cancer Trial Using Gene-Altered Cells After 3 Deaths", "print_headline": "Juno Halts Cancer Treatment Trial Using Gene-Altered Cells After 3 Deaths"}, "_id": "577eef9538f0d8658862afff", "word_count": "526", "multimedia": [], "pub_date": "2016-07-08T00:10:59+0000", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Juno Therapeutics Inc", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Cancer", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Genetic Engineering", "is_major": "Y", "rank": "3"}, {"name": "subject", "value": "Clinical Trials", "is_major": "N", "rank": "5"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "6"}, {"name": "organizations", "value": "Food and Drug Administration", "is_major": "Y", "rank": "7"}, {"name": "subject", "value": "Tests (Medical)", "is_major": "Y", "rank": "8"}], "blog": [], "subsection_name": null, "type_of_material": "News"}